155 related articles for article (PubMed ID: 7554467)
41. Hypogammaglobulinemia: fifty years later.
Conley ME
Clin Immunol; 2002 Sep; 104(3):201-3. PubMed ID: 12217328
[No Abstract] [Full Text] [Related]
42. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
Saha BK; Curtis SK; Vogler LB; Vihinen M
Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
[TBL] [Abstract][Full Text] [Related]
43. X-linked agammaglobulinemia. A clinical and molecular analysis.
Ochs HD; Smith CI
Medicine (Baltimore); 1996 Nov; 75(6):287-99. PubMed ID: 8982147
[TBL] [Abstract][Full Text] [Related]
44. Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia.
Vorechovský I; Luo L; Hertz JM; Frøland SS; Klemola T; Fiorini M; Quinti I; Paganelli R; Ozsahin H; Hammarström L; Webster AD; Smith CI
Hum Mutat; 1997; 9(5):418-25. PubMed ID: 9143921
[TBL] [Abstract][Full Text] [Related]
45. Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia.
Tani SM; Wang Y; Kanegane H; Futatani T; Pinto J; Vilela MM; Miyawaki T
Hum Mutat; 2002 Sep; 20(3):235-6. PubMed ID: 12204007
[TBL] [Abstract][Full Text] [Related]
46. Missense mutations affecting a conserved cysteine pair in the TH domain of Btk.
Vihinen M; Nore BF; Mattsson PT; Bäckesjö CM; Nars M; Koutaniemi S; Watanabe C; Lester T; Jones A; Ochs HD; Smith CI
FEBS Lett; 1997 Aug; 413(2):205-10. PubMed ID: 9280283
[TBL] [Abstract][Full Text] [Related]
47. Molecular analysis of Bruton's tyrosine kinase gene in Spain.
Rodríguez MC; Granados EL; Cerdán AF; Casariego GF
Hum Mutat; 2001; 18(1):84. PubMed ID: 11438999
[TBL] [Abstract][Full Text] [Related]
48. Mutations of Bruton's tyrosine kinase gene in Brazilian patients with X-linked agammaglobulinemia.
Ramalho VD; Oliveira Júnior EB; Tani SM; Roxo Júnior P; Vilela MM
Braz J Med Biol Res; 2010 Sep; 43(9):910-3. PubMed ID: 20721470
[TBL] [Abstract][Full Text] [Related]
49. Expression of the X-linked agammaglobulinemia gene, btk in B-cell acute lymphoblastic leukemia.
Katz FE; Lovering RC; Bradley LA; Rigley KP; Brown D; Cotter F; Chessells JM; Levinsky RJ; Kinnon C
Leukemia; 1994 Apr; 8(4):574-7. PubMed ID: 8152253
[TBL] [Abstract][Full Text] [Related]
50. SSCP at the BTK locus.
Vorechovský I
Hum Mol Genet; 1994 Jun; 3(6):1031. PubMed ID: 7951224
[No Abstract] [Full Text] [Related]
51. Novel insertions of Bruton tyrosine kinase in patients with X-linked agammaglobulinemia.
Okoh MP; Kainulainen L; Heiskanen K; Isa MN; Varming K; Ruuskanen O; Vihinen M
Hum Mutat; 2002 Dec; 20(6):480-1. PubMed ID: 12442285
[TBL] [Abstract][Full Text] [Related]
52. Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families.
Zhu Q; Zhang M; Winkelstein J; Chen SH; Ochs HD
Hum Mol Genet; 1994 Oct; 3(10):1899-900. PubMed ID: 7849721
[No Abstract] [Full Text] [Related]
53. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.
Hyvönen M; Saraste M
EMBO J; 1997 Jun; 16(12):3396-404. PubMed ID: 9218782
[TBL] [Abstract][Full Text] [Related]
54. B-cell-specific demethylation of BTK, the defective gene in X-linked agammaglobulinemia.
Parolini O; Rohrer J; Shapiro LH; Conley ME
Immunogenetics; 1995; 42(2):129-35. PubMed ID: 7541776
[TBL] [Abstract][Full Text] [Related]
55. A contiguous deletion syndrome of X-linked agammaglobulinemia and sensorineural deafness.
Richter D; Conley ME; Rohrer J; Myers LA; Zahradka K; Kelecić J; Sertić J; Stavljenić-Rukavina A
Pediatr Allergy Immunol; 2001 Apr; 12(2):107-11. PubMed ID: 11338284
[TBL] [Abstract][Full Text] [Related]
56. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
Hagemann TL; Chen Y; Rosen FS; Kwan SP
Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
[TBL] [Abstract][Full Text] [Related]
57. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
Kanegane H; Futatani T; Wang Y; Nomura K; Shinozaki K; Matsukura H; Kubota T; Tsukada S; Miyawaki T
J Allergy Clin Immunol; 2001 Dec; 108(6):1012-20. PubMed ID: 11742281
[TBL] [Abstract][Full Text] [Related]
58. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
[TBL] [Abstract][Full Text] [Related]
59. Hemizygous BTK Gene Variant Causing X-Linked Agammaglobulinemia in Two Siblings.
Saheb Sharif-Askari N; Hafezi S; Saheb Sharif-Askari F; Frommenwiler N; Halwani R
J Clin Immunol; 2023 Oct; 43(7):1533-1536. PubMed ID: 37341860
[No Abstract] [Full Text] [Related]
60. Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia.
Vihinen M; Zvelebil MJ; Zhu Q; Brooimans RA; Ochs HD; Zegers BJ; Nilsson L; Waterfield MD; Smith CI
Biochemistry; 1995 Feb; 34(5):1475-81. PubMed ID: 7849006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
